India has approved two COVID-19 vaccines – Covishield ‘from the Serum Institute of India and’ Covaxin ‘from Bharat Biotech – for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines should be given in two doses and should be stored at 2-8 ° C. Also read: Why people …
Read More »
The head of India’s drug regulator will deliver a press conference on Sunday, a day after his experts recommended allowing the emergency use in the country of the Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease ( Covid-19), according to reports. . The Comptroller General of Drugs of India …
Read More »
NEW DELHI: The launch of the vaccine in India will begin with the availability of two injections, Covishield from Oxford-Astra Zeneca and Covaxin homegrown from Bharat Biotech, and the Comptroller General of Drugs of India is expected to issue final approvals that they will probably be announced on Sunday. The …
Read More »
Union states and territories across the country are conducting a trial of the coronavirus vaccination process today. It is being carried out in 116 districts at 259 sites, the Health Ministry said on Saturday. The test will be carried out in an integral way of the COVID-19 vaccination process and …
Read More »
A senior Health Ministry official told The Hindu that Covishield is logistically more feasible for use and distribution in India, as it stores well between two and eight degrees Celsius. The Serum Institute of India (SII) said on Monday that it had applied to the Controller General of Drugs of …
Read More »
From insisting on seeking legal protection to waiving clinical trials, Pfizer’s application to the Comptroller General of Drugs of India (DCGI), seeking permission for the Emergency Use Authorization of its COVID-19 vaccine, it has too many buts and yes. The committee of subject matter experts constituted by DCGI is expected …
Read More »
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the country citing needs. not covered due to the pandemic and in interest. from …
Read More »
A volunteer in Chennai claimed to have suffered severe symptoms after injecting the vaccine. (Figurative) New Delhi: An investigation initiated by the Comptroller General of Drugs of India (DCGI) into a suspected “serious adverse event” allegedly suffered by a participant in the Oxford COVID-19 vaccine trial in Chennai found that …
Read More »
The Comptroller General of Medicines of India (DCGI) has granted permission to the Pune Serum Institute of India (SII) to resume its phase two and three clinical trials of the Oxford Covid-19 candidate vaccine in the country. DCGI VG Somani, in a letter to SII, has said that the institute’s …
Read More »